Experiences from intrathecal baclofen treatment based on medical records and patient- and proxy-reported outcome: a multicentre study

References

• Graham LA. Management of spasticity revisited. Age Ageing. 2013;42:435–441.
   PubMed Web of Science ®Google Scholar
• Stevenson VL. Rehabilitation in practice: spasticity management. Clin Rehabil. 2010;24:293–304.
   PubMed Web of Science ®Google Scholar
• Ertzgaard P, Anhammer M, Forsmark A. Regional disparities in botulinum toxin A (BoNT-A) therapy for spasticity in Sweden: budgetary consequences of closing the estimated treatment gap. Acta Neurol Scand. 2017;135:366–372.
   PubMed Web of Science ®Google Scholar
• Pandyan AD, Gregoric M, Barnes MP, et al. Spasticity: clinical perceptions, neurological realities and meaningful measurement. Disabil Rehabil. 2005;27:2–6.
   PubMed Web of Science ®Google Scholar
• Mathur SN, Chu SK, McCormick Z, et al. Long-term intrathecal baclofen: outcomes after more than 10 years of treatment. PMR. 2014;6:506–513.
   PubMedGoogle Scholar
• Hill DR, Bowery NG. 3H-baclofen and 3H-GABA bind to bicuculline-insensitive GABA B sites in rat brain. Nature. 1981;290:149–152.
   PubMed Web of Science ®Google Scholar
• Erwin A, Gudesblatt M, Bethoux F, et al. Intrathecal baclofen in multiple sclerosis: too little, too late? Mult Scler. 2011;17:623–629.
   PubMed Web of Science ®Google Scholar
• Natale M, Mirone G, Rotondo M, et al. Intrathecal baclofen therapy for severe spasticity: analysis on a series of 112 consecutive patients and future prospectives. Clin Neurol Neurosurg. 2012;114:321–325.
   PubMed Web of Science ®Google Scholar
• Posteraro F, Calandriello B, Galli R, et al. Timing of intrathecal baclofen therapy in persons with acquired brain injury: influence on outcome. Brain Inj. 2013;27:1671–1675.
   PubMed Web of Science ®Google Scholar
• Rekand T, Gronning M. Treatment of spasticity related to multiple sclerosis with intrathecal baclofen: a long-term follow-up. J Rehabil Med. 2011;43:511–514.
   PubMed Web of Science ®Google Scholar
• Draulans N, Vermeersch K, Degraeuwe B, et al. Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution. Clin Rehabil. 2013;27:1137–1143.
   PubMed Web of Science ®Google Scholar
• Gunnarsson S, Samuelsson K. Patient experiences with intrathecal baclofen as a treatment for spasticity - a pilot study. Disabil Rehabil. 2014;23:1–8.
   Google Scholar
• Bowling A, Rowe G, Lambert N, et al. The measurement of patients' expectations for health care: a review and psychometric testing of a measure of patients' expectations. Health Technol Assess. 2012;16(i–xii):1–509.
   Google Scholar
• Carver CS, Scheier MF. Dispositional optimism. Trends Cogn Sci (Regul Ed). 2014;18:293–299.
   PubMed Web of Science ®Google Scholar
• Winterling J, Glimelius B, Nordin K. The importance of expectations on the recovery period after cancer treatment. Psychooncology. 2008;17:190–198.
   PubMed Web of Science ®Google Scholar
• Rasmussen HN, Scheier MF, Greenhouse JB. Optimism and physical health: a meta-analytic review. Ann Behav Med. 2009;37:239–256.
   PubMed Web of Science ®Google Scholar
• Hanssen MM, Vancleef LM, Vlaeyen JW, et al. More optimism, less pain! The influence of generalized and pain-specific expectations on experienced cold-pressor pain. J Behav Med. 2014;37:47–58.
   PubMed Web of Science ®Google Scholar
• Wrosch C, Scheier MF. Personality and quality of life: the importance of optimism and goal adjustment. Qual Life Res. 2003;12:59–72.
   PubMed Web of Science ®Google Scholar
• Quinn TJ, Langhorne P, Stott DJ. Barthel index for stroke trials: development, properties, and application. Stroke. 2011;42:1146–1151.
   PubMed Web of Science ®Google Scholar
• Brooks R. EuroQol: the current state of play. Health Policy. 1996;37:53–72.
   PubMed Web of Science ®Google Scholar
• Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35:1095–1108.
   PubMed Web of Science ®Google Scholar
• Schwarzer R, Jerusalem M. Generalized self-efficacy scale. In: Johnston M, Wright S, Weinman J, editors. Measures in health psychology: a user’s portfolio. Causal and control beliefs. Windsor: NFER-NELSON; 1995. p. 35–37.
   Google Scholar
• Koskinen-Hagman M, Schwarzer R, Jerusalem M. Swedish version of the general self-efficacy scale [Internet]; 1999 [cited 2014 May 10]. Available from: http://userpage.fu-berlin.de/∼health/swedish.htm
   Google Scholar
• Love J, Moore CD, Hensing G. Validation of the Swedish translation of the general self-efficacy scale. Qual Life Res. 2012;21:1249–1253.
   PubMed Web of Science ®Google Scholar
• Farrar JT, Troxel AB, Stott C, et al. Validity, reliability, and clinical importance of change in a 0–10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial. Clin Ther. 2008;30:974–985.
   PubMed Web of Science ®Google Scholar
• Bryce TN, Budh CN, Cardenas DD, et al. Pain after spinal cord injury: an evidence-based review for clinical practice and research. Report of the National Institute on Disability and Rehabilitation Research Spinal Cord Injury Measures meeting. J Spinal Cord Med. 2007;30:421–440.
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113:9–19.
   PubMed Web of Science ®Google Scholar
• Farrar JT, Young JP, Jr., LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001; 94:149–158.
   PubMed Web of Science ®Google Scholar
• Hurst H, Bolton J. Assessing the clinical significance of change scores recorded on subjective outcome measures. J Manipulative Physiol Ther. 2004;27:26–35.
   PubMed Web of Science ®Google Scholar
• Muhonen T, Torkelson E. Kortversioner av frågeformulär inom arbets- och hälsopsykologi-om att mäta coping och optimism. [Short versions of inventories within work- and health-psychology]. Nordisk Psykologi. 2005;57:288–297. Swedish.
   Web of Science ®Google Scholar
• World Medical Association. Medical Association Declaration of Helsinki - ethical principles for medical research involving human subjects [Internet]. 2013 [cited 2017 June 2]. Available from: http://www.wma.net/en/30publications/10policies/b3/index.html
   Google Scholar
• Duncan PW, Lai SM, Tyler D, et al. Evaluation of proxy responses to the Stroke Impact Scale. Stroke. 2002; 33:2593–2599.
   PubMed Web of Science ®Google Scholar
• Sneeuw KC, Sprangers MA, Aaronson NK. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease. J Clin Epidemiol. 2002;55:1130–1143.
   PubMed Web of Science ®Google Scholar
• Wallen MA, Ziviani JM. Canadian occupational performance measure: impact of blinded parent-proxy ratings on outcome. Can J Occup Ther. 2012;79:7–14.
   PubMed Web of Science ®Google Scholar
• Meyers AR, Andresen EM. Enabling our instruments: accommodation, universal design, and access to participation in research. Arch Phys Med Rehabil. 2000;81:S5–S9.
   PubMed Web of Science ®Google Scholar
• Janssen B, Szende A. Self-reported population health: an international perspective based on EQ-5D. Dordrecht (The Netherlands): Springer; 2014.
   Google Scholar
• Krach LE, Nettleton A, Klempka B. Satisfaction of individuals treated long-term with continuous infusion of intrathecal baclofen by implanted programmable pump. Pediatr Rehabil. 2006;9:210–218.
   PubMedGoogle Scholar
• Natale M, D'Oria S, Nero VV, et al. Long-term effects of intrathecal baclofen in multiple sclerosis. Clin Neurol Neurosurg. 2016;143:121–125.
   PubMed Web of Science ®Google Scholar